Neural regulation of tumor immunity: emerging opportunities to enhance cancer immunotherapy. [PDF]
Chen X +7 more
europepmc +1 more source
Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm
Abstract Antipsychotic drugs targeting dopamine receptors have been used to treat schizophrenia for decades, primarily alleviating positive symptoms such as hallucinations and delusions. However, they provide limited benefit for cognitive and negative symptoms—major contributors to poor outcomes—and are frequently associated with significant side ...
Brian J. Morris, Judith A. Pratt
wiley +1 more source
Intra-Accumbal Infusions of an α<sub>2</sub>-Adrenoceptor Agonist and an α<sub>2</sub>-Adrenoceptor Antagonist Respectively Inhibit and Enhance Acetylcholine but Not Dopamine Efflux in the Nucleus Accumbens of Freely Moving Rats. [PDF]
Arai K +5 more
europepmc +1 more source
ABSTRACT Aims Cardiovascular autonomic neuropathy (CAN) is a severe form of diabetic neuropathy affecting approximately one in five people with diabetes and is a major predictor of cardiovascular mortality. Low‐grade inflammation may contribute to CAN development, but the exact inflammatory factors associated with CAN remain unclear.
Michelle Damgaard +9 more
wiley +1 more source
Varenicline-mediated cholinergic activation through α4β2 nAChR inhibits microglial neuroinflammation and alleviates neuropathic pain and depression following spinal cord injury. [PDF]
Cheng L +10 more
europepmc +1 more source
Neural regulation of tumor progression: implications for hepatocellular carcinoma. [PDF]
Chen Y, Long Z, Zang YS, Wu D.
europepmc +1 more source
Analysis of the Efficacy of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease, Literature Review. [PDF]
Petrov W +11 more
europepmc +1 more source
The sleep-wake cycle: molecular mechanisms, disorders, and therapeutic targets in the context of energy metabolism. [PDF]
Li JK, Wang RY, Meng XY, Kang JS.
europepmc +1 more source
Neural-immune-cardiovascular axis: from mechanistic crosstalk to therapeutic targets in cardiovascular disease. [PDF]
Cheng J +8 more
europepmc +1 more source

